LGT Fund Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.92M | Buy |
63,104
+4,016
| +7% | +$186K | 0.26% | 94 |
|
|
2025
Q1 | $3.6M | Hold |
59,088
| – | – | 0.32% | 66 |
|
|
2024
Q4 | $3.34M | Buy |
59,088
+3,338
| +6% | +$189K | 0.29% | 72 |
|
|
2024
Q3 | $3M | Buy |
55,750
+38,732
| +228% | +$2.08M | 0.31% | 82 |
|
|
2024
Q2 | $707K | Buy |
+17,018
| New | +$707K | 0.09% | 129 |
|
|
2023
Q1 | – | Sell |
-20,156
| Closed | -$1.45M | – | 141 |
|
|
2022
Q4 | $1.45M | Buy |
20,156
+156
| +0.8% | +$11.2K | 0.63% | 58 |
|
|
2022
Q3 | $1.42M | Sell |
20,000
-30,598
| -60% | -$2.18M | 0.67% | 54 |
|
|
2022
Q2 | $3.9M | Buy |
50,598
+2,483
| +5% | +$191K | 0.57% | 42 |
|
|
2022
Q1 | $3.55M | Buy |
+48,115
| New | +$3.55M | 0.47% | 56 |
|